Malignant neoplasm of ovary
Semantic Scholar uses AI to extract papers important to this topic.
Most ovarian cancer patients are diagnosed at an advanced stage (67%) and prospects for significant improvement in… Expand BACKGROUND
Standard chemotherapy for newly diagnosed ovarian cancer is a platinum-taxane combination. The Gynecologic Oncology… Expand In a recent report, [Zhang et al. (2003) N. Engl. J. Med. 348, 203-213], the presence of CD3+ tumor-infiltrating lymphocytes… Expand Purpose: The purpose of this study was to determine the accuracy, precision, and linearity of the CellSearch system and evaluate… Expand Germline mutations in BRCA1 and BRCA2 confer high risks of breast and ovarian cancer, but the average magnitude of these risks is… Expand PURPOSE
In randomized trials the combination of cisplatin and paclitaxel was superior to cisplatin and cyclophosphamide in… Expand BACKGROUND
New technologies for the detection of early-stage ovarian cancer are urgently needed. Pathological changes within an… Expand BACKGROUND
Chemotherapy combinations that include an alkylating agent and a platinum coordination complex have high response… Expand A strong candidate for the 17q-linked BRCA1 gene, which influences susceptibility to breast and ovarian cancer, has been… Expand Carcinoma of the breast and ovary account for one-third of all cancers occurring in women and together are responsible for… Expand